Consent and Human Cloning
The hardest ethical questions about cloning are not about the technique — they are about who consents, and on whose behalf.
Consent sits at the centre of modern biomedical ethics. It is also one of the hardest concepts to apply to reproductive cloning, because the entity most affected by the decision — the resulting child — does not yet exist and cannot agree to anything.
Consent for the future person
A future person cannot consent to the conditions of their own creation. This is true of ordinary reproduction as well, and bioethicists have written carefully about what that means. The distinctive concern with reproductive cloning is that the conditions are unusual and explicit:
- The clone would be produced with a particular genetic identity in mind.
- The clone would be produced for an explicit purpose chosen by adults.
- The clone would carry, from the start, the cultural expectation of being a copy of someone else.
None of this is true of conventional reproduction in the same way. The asymmetry between the chooser and the person chosen for is sharper.
Consent for participants
Reproductive cloning would involve more than the future child. It would draw in:
- Egg donors — people willing to undergo medical procedures to provide eggs.
- Gestational carriers — people willing to carry the resulting pregnancy.
- Genetic donors — the person whose nuclear DNA is being copied, if living.
Each of these consents matters, and each is subject to its own pressures — financial, social, familial. The bioethics literature on assisted reproduction has long recognised that consent in these contexts is not a single, simple yes-or-no. It is shaped by inequality and by power.
Consent for the genetic donor
If the genetic donor is alive, the question of their consent is at least available in principle. Two cases are harder:
- Children. A child cannot meaningfully consent to having their genome used in this way. Most ethical frameworks would treat any such use as impermissible.
- Deceased people. A person who has died cannot consent. Using their genome in reproductive cloning raises serious questions about how their wishes — or family members’ wishes — could be respected.
The non-consensual case — cloning someone without their knowledge or agreement — would face overlapping legal problems under privacy, identity, and reproductive-health rules in essentially every jurisdiction.
Consent and commercialisation
Powerful reproductive technologies attract markets. Where a market exists, the people most likely to provide eggs, surrogacy services, or other biological inputs are often those with the fewest alternatives. The bioethics literature has worried about this pattern for decades in the context of assisted reproduction generally. Reproductive cloning would intensify it.
This is one reason why most bioethics frameworks treat the commercialisation of reproductive cloning as especially objectionable. The risk is not only that consent would be poorly informed, but that it would be structurally constrained.
Key takeaway
The consent problems around reproductive cloning are not solvable by paperwork. They are built into the situation: future persons cannot consent at all, and the consents of participants are shaped by inequality and pressure.
What this implies for research
Therapeutic cloning — research on cells, not on producing a person — does not face the same set of consent problems, but it is still bound by ordinary biomedical-research consent rules. Cells used in research come from people, and those people have to agree, in informed and revocable ways, to that use. Different jurisdictions enforce these rules with different levels of strictness.